By Scott Gottlieb (original source The Wall Street Journal)
“The Covid epidemic in the South has strained the country’s capacity to keep up with the demand for testing. Six months into the pandemic, we still don’t have enough supplies, equipment or lab services. There’s no national plan for effectively allocating the capacity that does exist or providing a sufficient surge where it’s needed suddenly.
The system is overwhelmed. Major commercial labs are reporting turnaround times of around seven days, and patients say it’s often longer. Without a confirmed diagnosis, many infected patients don’t isolate themselves or get treatments.
The intelligence community has warned for years that pandemic disease was a national-security threat on par with that of terrorism, weapons of mass destruction and cyberattacks. It’s essential to increase American capacity to detect these events, contain them, and manufacture reliable countermeasures.”
Click here to read more
Ambassador Deborah Birx, MD, Unveils Urgent Insights on Avian Flu, COVID-19, and HMPV
On January 13, 2025, the Animal and Plant Health Inspection Service (APHIS), part of the United States Department of Agriculture (USDA), announced that it has…
Thought Leader: Deborah Birx
Dr. Scott Gottlieb to keynote MM+M Transform in April
Former FDA commissioner, Dr. Scott Gottlieb will take the stage for the brand’s 11th annual spring conference. Dr. Scott Gottlieb, who served as 23rd commissioner…
Thought Leader: Scott Gottlieb
More needs to be done to prevent bird flu outbreak, says Dr. Scott Gottlieb
Dr. Scott Gottlieb, former FDA Commissioner, joins CNBC’s ‘Squawk Box’ to discuss concerns around a bird flu outbreak in the U.S. To host Dr. Gottlieb…
Thought Leader: Scott Gottlieb
